1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Alabama >
  6. Organogenesis Acquires NuTech Medical

M&A Deal Summary

Organogenesis Acquires NuTech Medical

On March 28, 2017, Organogenesis acquired life science company NuTech Medical

Acquisition Highlights
  • This is Organogenesis’ 3rd transaction in the Life Science sector.
  • This is Organogenesis’ 3rd transaction in the United States.
  • This is Organogenesis’ 1st transaction in Alabama.

M&A Deal Summary
Date 2017-03-28
Target NuTech Medical
Sector Life Science
Buyer(s) Organogenesis
Deal Type Add-on Acquisition

Target

NuTech Medical

Birmingham, Alabama, United States
NuTech Medical, Inc. is a provider of amniotic products for a variety of surgical and wound care needs. NuTech Medical’s portfolio includes an amniotic product line for both soft tissue and bone applications, utilized in multiple markets including wound healing and surgery.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Organogenesis

Canton, Massachusetts, United States
Category Company
Founded 1985
Sector Life Science
Employees869
Revenue 482M USD (2024)
DESCRIPTION

Organogenesis is a provider of regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products for advanced wound care, orthopedics and spine. Organogenesis was established in 1985 and is headquartered in Canton, Massachusetts.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Add-on Acquisition M&A Deals 2 of 2
State: Alabama M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-17 Dermagraft

Canton, Massachusetts, United States

Dermagraft is a provider of nonhealing diabetic foot ulcers. Dermagraft is headquartered in Canton, Massachusetts.

Buy -
Mergr

Solution for

Product

Company

Legal